InvestmentSQURPHARMA
SQURPHARMA Approves Factory BMRE Investment
Announcement summary
- What happened
- SQURPHARMA approved a factory BMRE investment.
- Purpose
- BMRE of the company’s factory
- Facility / project
- Factory BMRE
- Company
- Square Pharmaceuticals PLC.
- Announcement published
Original announcement
The Board of Directors has recommended 100% cash dividend for the year ended June 30, 2022. The Board has also approved Tk. 300.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 24.12.2022, Time: 10:00 AM, Venue: Digital Platform. Record Date: 28.11.2022. (cont.)
বাংলা অনুবাদ — BullBD
This is a BullBD translation of the published corporate disclosure.
পরিচালনা পর্ষদ 30 জুন, 2022 তারিখে সমাপ্ত বছরের জন্য 100% নগদ লভ্যাংশ সুপারিশ করেছে। ভবিষ্যতে সম্প্রসারণের জন্য BMRE, ক্যাপিটাল মেশিনারিজ এবং জমির জন্য 300.00 কোটি। AGM এর তারিখ: 24.12.2022, সময়: 10:00 AM, ভেন্যু: ডিজিটাল প্ল্যাটফর্ম। রেকর্ডের তারিখ: 28.11.2022। (চলবে)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 6354ae32b2c258419476a748
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SQURPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.